// App-Quantinova.ai

36 : 18F-DCFPyL PSMA PET imaging compared to conventional imaging in the detection of pelvic nodal metastases in patients with locally advanced or oligometastatic prostate cancer.

Researchers

Presenter

  • Ashanda Rosetta Patrice Esdaille

Principal Investigators

  • Edward Lawrence

  • Christos Kyriakopoulos

  • Brian Johnson

  • Alejandro Roldn-Alzate

  • Wei Huang

  • David J. Beebe

  • Hamid Emamekhoo

  • Shane Wells

  • Joshua Michael Lang

  • Steve Y. Cho

  • David Frazier Jarrard

Medical Centers

  • Univeristy of Wisconsin, Madison, WI

  • University of Wisconsin School of Medicine and Public Health, Madison, WI

  • University of Wisconsin Comprehensive Cancer Center, Madison, WI

  • Univeristy of Wisconsin, Madison, WI

  • University of Wisconsin Biomedical Engineering, Madison, WI

  • Univ. of Wisconsin-Madison, Madison, WI.

  • Department of Biomedical Engineering, University of Wisconsin, Madison, WI

  • University of Wisconsin SMPH, Department of Radiology, University of Wisconsin Carbone Cancer Center, Madison, WI

  • University of Wisconsin Hosp and Clinics, Madison, WI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Folate Hydrolase 1

Drug/Treatment

  • 18F-DCFPyL

  • Docetaxel

  • Androgen Tear

Outcome

  • N/A


Study Design

  • Open Label

  • Single Arm

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A